View in EDS

Cost-effectiveness of dapagliflozin compared to DPP-4 inhibitors as combination therapy with metformin in the treatment of type 2 diabetes mellitus without established cardiovascular disease in Colombia.

Saved in:
Bibliographic Details
Title: Cost-effectiveness of dapagliflozin compared to DPP-4 inhibitors as combination therapy with metformin in the treatment of type 2 diabetes mellitus without established cardiovascular disease in Colombia.
Authors: Lasalvia P; Department of Economic Studies, NeuroEconomix, Bogota, Colombia., Gil-Rojas Y; Department of Economic Studies, NeuroEconomix, Bogota, Colombia., García Á; Cardiology Unit, San Ignacio University Hospital. Pontificia Universidad Javeriana, Bogotá, Colombia.
Source: Expert review of pharmacoeconomics & outcomes research [Expert Rev Pharmacoecon Outcomes Res] 2022 Sep; Vol. 22 (6), pp. 955-964. Date of Electronic Publication: 2022 Mar 08.
Publication Type: Journal Article
Journal Info: Publisher: Taylor & Francis Country of Publication: England NLM ID: 101132257 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1744-8379 (Electronic) Linking ISSN: 14737167 NLM ISO Abbreviation: Expert Rev Pharmacoecon Outcomes Res Subsets: MEDLINE
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 35259045
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Cost-effectiveness of dapagliflozin compared to DPP-4 inhibitors as combination therapy with metformin in the treatment of type 2 diabetes mellitus without established cardiovascular disease in Colombia.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Lasalvia+P%22">Lasalvia P</searchLink>; Department of Economic Studies, NeuroEconomix, Bogota, Colombia.<br /><searchLink fieldCode="AU" term="%22Gil-Rojas+Y%22">Gil-Rojas Y</searchLink>; Department of Economic Studies, NeuroEconomix, Bogota, Colombia.<br /><searchLink fieldCode="AU" term="%22García+Á%22">García Á</searchLink>; Cardiology Unit, San Ignacio University Hospital. Pontificia Universidad Javeriana, Bogotá, Colombia.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101132257%22">Expert review of pharmacoeconomics & outcomes research</searchLink> [Expert Rev Pharmacoecon Outcomes Res] 2022 Sep; Vol. 22 (6), pp. 955-964. <i>Date of Electronic Publication: </i>2022 Mar 08.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Taylor+%26+Francis%22">Taylor & Francis </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>101132257 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1744-8379 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2214737167%22">14737167 </searchLink><i>NLM ISO Abbreviation: </i>Expert Rev Pharmacoecon Outcomes Res <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=35259045
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1080/14737167.2022.2044310
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 955
    Titles:
      – TitleFull: Cost-effectiveness of dapagliflozin compared to DPP-4 inhibitors as combination therapy with metformin in the treatment of type 2 diabetes mellitus without established cardiovascular disease in Colombia.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Lasalvia P
      – PersonEntity:
          Name:
            NameFull: Gil-Rojas Y
      – PersonEntity:
          Name:
            NameFull: García Á
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 09
              Text: 2022 Sep
              Type: published
              Y: 2022
          Identifiers:
            – Type: issn-electronic
              Value: 1744-8379
          Numbering:
            – Type: volume
              Value: 22
            – Type: issue
              Value: 6
          Titles:
            – TitleFull: Expert review of pharmacoeconomics & outcomes research
              Type: main
ResultId 1